Se Connecter/S’inscrire
Votre courriel a été envoyé.
1850 NW 69th Ave
Plantation, FL 33313
GBI Biomanufacturing HQ · Industriel Propriété À vendre
Certaines informations ont été traduites automatiquement.
Faits saillants de l'investissement
- TRIPLE-NET LEASE – SEVEN YEARS REMAINING: 100% leased to GBI Biomanufacturing through May 2033 with minimal landlord responsibilities.
- NEW FLORIDA STEM CELL LEGISLATION: Recent state law enabling regenerative treatments supports increased demand for stem cell manufacturing capacity.
- STRATEGIC BROWARD COUNTY LOCATION: Access to Sunrise Boulevard, Interstate 95, Florida’s Turnpike, and Ft. Lauderdale-Hollywood International Airport.
- VALUE-ADD OPPORTUNITY: Value-Add Opportunity - 9.84% Pro Forma Cap Rate.
- LIFE SCIENCES MANUFACTURING FACILITY: Specialized laboratory and biologics production infrastructure designed for pharmaceutical-grade operations.
- MARK-TO-MARKET OPPORTUNITY: Tenant currently pays below-market rent of $16.20/SF, compared to an estimated current market rent of $24.00/SF.
Résumé de l'annonce
GBI Biomanufacturing Headquarters, located at 1850 NW 69th Avenue in Plantation, Florida, a 38,000 square-foot biologics manufacturing and life sciences facility in Broward County. The property is fully leased to GBI Biomanufacturing, Inc., a contract development and manufacturing organization (CDMO) specializing in mammalian cell culture development and cGMP biologics production.
The asset is secured by a triple-net lease with approximately seven years of remaining term through May 31, 2033, providing stable cash flow while minimizing landlord responsibilities, as the tenant is responsible for taxes, insurance, operating expenses, and maintenance. The lease also includes 2.6 percent annual rent escalations, providing consistent income growth throughout the remaining primary lease term.
The facility supports highly specialized biologics manufacturing operations requiring tailored laboratory buildouts, advanced mechanical systems, and pharmaceutical-grade production infrastructure. GBI has invested approximately $26 million into the facility, demonstrating significant tenant commitment while creating substantial barriers to relocation.
The investment also offers a clear value-add component through the lease renewal structure. Upon the first renewal option, rent resets to 90 percent of prevailing market rent, representing over 40 percent mark-to-market rent upside based on current underwriting. This structure provides the ability to significantly increase income at the end of the primary term, producing a projected 9.84 percent cap rate in year seven.
Additionally, the property benefits from Florida’s recently enacted stem cell legislation, which allows certain regenerative treatments to be offered within the state and has helped increase demand for stem cell manufacturing capacity. GBI has indicated the expanded facility will support the production of up to one million stem cell units annually, positioning the asset within a rapidly growing segment of the biotechnology sector.
The asset is secured by a triple-net lease with approximately seven years of remaining term through May 31, 2033, providing stable cash flow while minimizing landlord responsibilities, as the tenant is responsible for taxes, insurance, operating expenses, and maintenance. The lease also includes 2.6 percent annual rent escalations, providing consistent income growth throughout the remaining primary lease term.
The facility supports highly specialized biologics manufacturing operations requiring tailored laboratory buildouts, advanced mechanical systems, and pharmaceutical-grade production infrastructure. GBI has invested approximately $26 million into the facility, demonstrating significant tenant commitment while creating substantial barriers to relocation.
The investment also offers a clear value-add component through the lease renewal structure. Upon the first renewal option, rent resets to 90 percent of prevailing market rent, representing over 40 percent mark-to-market rent upside based on current underwriting. This structure provides the ability to significantly increase income at the end of the primary term, producing a projected 9.84 percent cap rate in year seven.
Additionally, the property benefits from Florida’s recently enacted stem cell legislation, which allows certain regenerative treatments to be offered within the state and has helped increase demand for stem cell manufacturing capacity. GBI has indicated the expanded facility will support the production of up to one million stem cell units annually, positioning the asset within a rapidly growing segment of the biotechnology sector.
Faits sur la propriété
| Type de vente | Investissement pour loyer hypernet | Aire du bâtiment louable | 37 911 pi² |
| Taux de capitalisation | 6% | Nombre d’étages | 1 |
| Type de propriété | Industriel | Année de construction/rénovation | 1980/2023 |
| Sous-type de propriété | Entrepôt | Location | Unique |
| Classe d’immeuble | B | Ratio de stationnement | 3,1/1 000 pi² |
| Taille du lot | 2,31 AC | Nbre d’entrées dans les portes/au niveau du sol | 1 |
| Zonage | I-LP, Plantation | ||
| Type de vente | Investissement pour loyer hypernet |
| Taux de capitalisation | 6% |
| Type de propriété | Industriel |
| Sous-type de propriété | Entrepôt |
| Classe d’immeuble | B |
| Taille du lot | 2,31 AC |
| Aire du bâtiment louable | 37 911 pi² |
| Nombre d’étages | 1 |
| Année de construction/rénovation | 1980/2023 |
| Location | Unique |
| Ratio de stationnement | 3,1/1 000 pi² |
| Nbre d’entrées dans les portes/au niveau du sol | 1 |
| Zonage | I-LP, Plantation |
Commodités
- Ligne d'autobus
Impôts fonciers
| Numéro de lot | 49-41-34-41-0090 | Évaluation des bâtiments | 8 201 944 $ CAD |
| Évaluation du terrain | 1 652 186 $ CAD | Évaluation totale | 9 854 130 $ CAD |
Impôts fonciers
Numéro de lot
49-41-34-41-0090
Évaluation du terrain
1 652 186 $ CAD
Évaluation des bâtiments
8 201 944 $ CAD
Évaluation totale
9 854 130 $ CAD
1 de 10
Vidéos
Visite extérieure 3D Matterport
Visite 3D Matterport
Photos
Vue depuis la rue
Rue
Carte
